vs
太平洋生物科学（ASMB）与CAPRICOR THERAPEUTICS, INC.（CAPR）财务数据对比。点击上方公司名可切换其他公司
CAPRICOR THERAPEUTICS, INC.的季度营收约是太平洋生物科学的1.0倍（$11.1M vs $10.8M），CAPRICOR THERAPEUTICS, INC.净利率更高（-63.9% vs -85.2%，领先21.3%），太平洋生物科学同比增速更快（57.6% vs -7.9%），太平洋生物科学自由现金流更多（$-15.2M vs $-15.3M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
ASMB vs CAPR — 直观对比
营收规模更大
CAPR
是对方的1.0倍
$10.8M
营收增速更快
ASMB
高出65.5%
-7.9%
净利率更高
CAPR
高出21.3%
-85.2%
自由现金流更多
ASMB
多$110.1K
$-15.3M
损益表 — Q3 FY2025 vs Q4 FY2024
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $11.1M |
| 净利润 | $-9.2M | $-7.1M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | -69.1% |
| 净利率 | -85.2% | -63.9% |
| 营收同比 | 57.6% | -7.9% |
| 净利润同比 | 4.3% | -833.8% |
| 每股收益（稀释后） | $-0.72 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBCAPR
| Q3 25 | $10.8M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $7.4M | $11.1M | ||
| Q3 24 | $6.8M | $2.3M | ||
| Q2 24 | $8.5M | $4.0M | ||
| Q1 24 | $5.8M | $4.9M | ||
| Q4 23 | — | $12.1M |
净利润ASMBCAPR
| Q3 25 | $-9.2M | — | ||
| Q2 25 | $-10.2M | — | ||
| Q1 25 | $-8.8M | — | ||
| Q4 24 | — | $-7.1M | ||
| Q3 24 | $-9.6M | $-12.6M | ||
| Q2 24 | $-11.2M | $-11.0M | ||
| Q1 24 | $-9.1M | $-9.8M | ||
| Q4 23 | — | $-762.1K |
营业利润率ASMBCAPR
| Q3 25 | -100.9% | — | ||
| Q2 25 | -115.2% | — | ||
| Q1 25 | -105.5% | — | ||
| Q4 24 | — | -69.1% | ||
| Q3 24 | -160.1% | -575.2% | ||
| Q2 24 | -143.0% | -291.9% | ||
| Q1 24 | -185.5% | -209.2% | ||
| Q4 23 | — | -10.6% |
净利率ASMBCAPR
| Q3 25 | -85.2% | — | ||
| Q2 25 | -105.9% | — | ||
| Q1 25 | -93.6% | — | ||
| Q4 24 | — | -63.9% | ||
| Q3 24 | -140.4% | -555.2% | ||
| Q2 24 | -130.7% | -277.0% | ||
| Q1 24 | -156.9% | -199.6% | ||
| Q4 23 | — | -6.3% |
每股收益（稀释后）ASMBCAPR
| Q3 25 | $-0.72 | — | ||
| Q2 25 | $-1.33 | — | ||
| Q1 25 | $-1.17 | — | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | $-1.51 | $-0.38 | ||
| Q2 24 | $-1.98 | $-0.35 | ||
| Q1 24 | $-1.66 | $-0.31 | ||
| Q4 23 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $151.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $182.7M | $145.5M |
| 总资产 | $240.0M | $170.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASMBCAPR
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | $151.5M | ||
| Q3 24 | $28.5M | $85.0M | ||
| Q2 24 | $19.2M | $29.5M | ||
| Q1 24 | $18.7M | $39.9M | ||
| Q4 23 | — | $39.5M |
股东权益ASMBCAPR
| Q3 25 | $182.7M | — | ||
| Q2 25 | $18.1M | — | ||
| Q1 25 | $27.1M | — | ||
| Q4 24 | $33.4M | $145.5M | ||
| Q3 24 | $26.0M | $68.3M | ||
| Q2 24 | $34.7M | $11.5M | ||
| Q1 24 | $32.6M | $18.4M | ||
| Q4 23 | — | $22.6M |
总资产ASMBCAPR
| Q3 25 | $240.0M | — | ||
| Q2 25 | $80.8M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $119.2M | $170.5M | ||
| Q3 24 | $100.3M | $93.0M | ||
| Q2 24 | $115.3M | $38.3M | ||
| Q1 24 | $119.9M | $49.4M | ||
| Q4 23 | — | $58.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-14.8M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-15.3M |
| 自由现金流率自由现金流/营收 | -140.7% | -137.3% |
| 资本支出强度资本支出/营收 | 0.4% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-41.2M |
8季度趋势，按日历期对齐
经营现金流ASMBCAPR
| Q3 25 | $-15.1M | — | ||
| Q2 25 | $-16.8M | — | ||
| Q1 25 | $-23.4M | — | ||
| Q4 24 | $-51.1M | $-14.8M | ||
| Q3 24 | $-15.2M | $-11.6M | ||
| Q2 24 | $-17.1M | $-12.3M | ||
| Q1 24 | $-18.4M | $-1.3M | ||
| Q4 23 | — | $-11.6M |
自由现金流ASMBCAPR
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | $-15.3M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | $-17.1M | $-12.3M | ||
| Q1 24 | $-18.4M | $-1.9M | ||
| Q4 23 | — | $-12.2M |
自由现金流率ASMBCAPR
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | -137.3% | ||
| Q3 24 | — | -515.2% | ||
| Q2 24 | -200.6% | -310.9% | ||
| Q1 24 | -317.7% | -38.3% | ||
| Q4 23 | — | -100.5% |
资本支出强度ASMBCAPR
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | 4.4% | ||
| Q3 24 | 0.0% | 0.4% | ||
| Q2 24 | 0.2% | 1.5% | ||
| Q1 24 | 0.2% | 12.4% | ||
| Q4 23 | — | 4.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
